Literature DB >> 16156512

Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.

Hana Rauchová1, Olga Pechánová, Jaroslav Kunes, Martina Vokurková, Zdenka Dobesová, Josef Zicha.   

Abstract

The aim of this study was to evaluate the production of superoxide anions as well as their role in the induction and/or maintenance of high blood pressure in rats with N(omega)-nitro-L-arginine methyl ester (L-NAME)-induced hypertension. In the preventive study, we compared adult Wistar rats treated with L-NAME for 4 weeks with L-NAME-treated rats that were simultaneously given N-acetylcysteine (NAC) in their drinking water. Basal blood pressure, superoxide production, conjugated dienes concentration and NO synthase (NOS) activity were measured at the end of the experiment. Chronic NOS inhibition by L-NAME treatment increased blood pressure, enhanced superoxide production in the aorta and elevated the concentration of conjugated dienes in the heart and kidney. All these changes were prevented by simultaneous NAC administration, which augmented NOS activity in L-NAME-treated rats. In the therapeutic study, the effects of chronic NAC treatment were studied in rats with established hypertension which developed during 4 weeks of L-NAME administration. The blood pressure effects of chronic NAC treatment in established L-NAME hypertension were only moderate, although this treatment also restored NOS activity and lowered conjugated dienes in the heart and kidney. Since chronic NAC treatment had better preventive than therapeutic effects, it seems that reactive oxygen species play a more important role in the induction than in the maintenance of L-NAME hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156512     DOI: 10.1291/hypres.28.475

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

1.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

2.  Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice.

Authors:  Mohd Shahid; Joseph Francis; Khalid Matrougui; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-21

3.  Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension.

Authors:  Jerzy Bełtowski; Anna Jamroz-Wiśniewska; Grazyna Wójcicka; Ewelina Lowicka; Andrzej Wojtak
Journal:  Mol Cell Biochem       Date:  2008-08-09       Impact factor: 3.396

Review 4.  Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis.

Authors:  Xin-Fang Leong; Chun-Yi Ng; Kamsiah Jaarin
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

5.  Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients.

Authors:  Arsalan Khaledifar; Mahmoud Mobasheri; Soleiman Kheiri; Zeinab Zamani
Journal:  ARYA Atheroscler       Date:  2015-01

6.  N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure.

Authors:  Beverly Giam; Po-Yin Chu; Sanjaya Kuruppu; A Ian Smith; Duncan Horlock; Helen Kiriazis; Xiao-Jun Du; David M Kaye; Niwanthi W Rajapakse
Journal:  Physiol Rep       Date:  2016-04-13

7.  Effect of iron oxide nanoparticles on vascular function and nitric oxide production in acute stress-exposed rats.

Authors:  S Líšková; P Bališ; A Mičurová; M Kluknavský; M Okuliarová; A Puzserová; M Škrátek; I Sekaj; J Maňka; P Valovič; I Bernátová
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

8.  Reactive Oxygen Species and Nuclear Factor Erythroid 2-Related Factor 2 Activation in Diabetic Nephropathy: A Hidden Target.

Authors:  Shaaban Abdo; Shao-Ling Zhang; John S D Chan
Journal:  J Diabetes Metab       Date:  2015-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.